Chronic pancreatitis is characterised by complex, multifactorial pain affecting 80–90% of patients. Pain arises from overlapping nociceptive and neuropathic mechanisms, often accompanied by CNS ...

Acute pancreatitis (AP) is one of the most common acute digestive disorders worldwide, and its most feared complication-persistent organ failure-drives mortality rates of 30% to 50%.

Medscape reports that cancer is the top searched disease in AI queries across nine countries, reflecting the complexity of oncology and advancements in treatment.

Metastatic pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid cancers, portending poor patient outcomes ...

Up until now, I have talked about 'lifestyle renovation' from various angles, such as carbohydrate restriction, gut health, and the importance of protein.Today, I will talk about the 'final form ...

Precision Medicine in the Best and Worst of Times - Hope, but Not for All / C.A.I.R.O Journal Club, COGC 2026, Community Oncology ...

Approval Creates Possibility, Access Creates Impact / ASCO, cancer, cancer care access, Cancer Drug Access, Cancer ...

Blood test shows promise in detecting pancreatic cancer early—a 'Holy Grail' for the field Pancreatic cancer is typically ...

ABC News' Lara Spencer reports on a blood test that could be used to detect the most common type of pancreatic cancer at an early stage.

Dr. Rajesh Keswani, a Northwestern Medicine gastroenterologist, says the hope is to find the cancer in its earliest stage for more success stories.

La FDA aprobó un nuevo tratamiento oral que incrementa de cuatro a 13 meses la expectativa de vida en pacientes con cáncer de páncreas avanzado. El fármaco beneficia a personas que no responden a la ...

When the news broke that the Food and Drug Administration approved a new drug for pancreatic cancer patients, it gave patients fighting the disease a glimmer of long-awaited hope. For years, the team ...